COL11A1 promotes tumor progression and predicts poor clinical outcome in ovarian cancer

Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia

(2011) Erik S. Knudsen et al.   BREAST CANCER RESEARCH AND TREATMENT

The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer

(2011) Shogo Yamamura et al.   INTERNATIONAL JOURNAL OF CANCER

Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1

(2010) Hoon Kim et al.   BMC Medical Genomics

p53 Dysfunction by Xeroderma Pigmentosum Group C Defects Enhance Lung Adenocarcinoma Metastasis via Increased Mmp1 Expression

(2010) Y.-H. Wu et al.   CANCER RESEARCH

Gene Expression Profile ofBRCAness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer

(2010) Panagiotis A. Konstantinopoulos et al.   JOURNAL OF CLINICAL ONCOLOGY

Roles of TGFβ in metastasis

(2008) David Padua et al.   CELL RESEARCH

Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome

(2008) R. W. Tothill et al.   CLINICAL CANCER RESEARCH

Glucocorticoid receptor-mediated regulation of MMP9 gene expression in human ovarian surface epithelial cells

(2008) Michael T. Rae et al.   FERTILITY AND STERILITY

The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin

(2008) Hilary A. Kenny et al.   JOURNAL OF CLINICAL INVESTIGATION